A share price of Neumora Therapeutics Inc [NMRA] is currently trading at $1.43, up 6.72%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The NMRA shares have gain 1.42% over the last week, with a monthly amount drifted -23.94%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Neumora Therapeutics Inc [NASDAQ: NMRA] stock has seen the most recent analyst activity on March 10, 2025, when William Blair downgraded its rating to a Mkt Perform. Previously, Stifel downgraded its rating to Hold on March 07, 2025, and dropped its price target to $2. On March 07, 2025, downgrade downgraded it’s rating to Neutral. RBC Capital Mkts downgraded its rating to a Sector Perform and decreased its price target to $4 on January 02, 2025. JP Morgan downgraded its rating to a Neutral and reduced its price target to $15 on November 05, 2024. H.C. Wainwright started tracking with a Buy rating for this stock on October 01, 2024, and assigned it a price target of $30. In a note dated July 22, 2024, Needham initiated an Buy rating and provided a target price of $23 on this stock.
Neumora Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $1.30 and $18.61. Currently, Wall Street analysts expect the stock to reach $3 within the next 12 months. Neumora Therapeutics Inc [NASDAQ: NMRA] shares were valued at $1.43 at the most recent close of the market. An investor can expect a potential return of 109.79% based on the average NMRA price forecast.
Analyzing the NMRA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.77, Equity is -0.69 and Total Capital is -0.92. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3167 points at the first support level, and at 1.2033 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.4867, and for the 2nd resistance point, it is at 1.5433.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Neumora Therapeutics Inc [NASDAQ:NMRA] is 10.51. Further, the Quick Ratio stands at 10.51, while the Cash Ratio is 4.76.
Transactions by insiders
Recent insider trading involved BERNS PAUL L, that happened on Feb 18 ’25 when 13871.0 shares were sold., Milligan Michael Lee completed a deal on Feb 18 ’25 to sell 1978.0 shares. Meanwhile, Chief Strategy Officer Aurora Daljit Singh sold 8565.0 shares on Feb 18 ’25.
